CLEANSPARK INC (CLSK) Fundamental Analysis & Valuation

NASDAQ:CLSK • US18452B2097

Current stock price

9.975 USD
-0.22 (-2.21%)
Last:

This CLSK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLSK Profitability Analysis

1.1 Basic Checks

  • CLSK had negative earnings in the past year.
  • CLSK had a negative operating cash flow in the past year.
  • In the past 5 years CLSK reported 4 times negative net income.
  • In the past 5 years CLSK reported 4 times negative operating cash flow.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • CLSK has a worse Return On Assets (-8.03%) than 61.09% of its industry peers.
  • CLSK's Return On Equity of -19.32% is in line compared to the rest of the industry. CLSK outperforms 40.36% of its industry peers.
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROIC N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 53.08%, CLSK is doing worse than 67.27% of the companies in the same industry.
  • CLSK's Gross Margin has improved in the last couple of years.
  • CLSK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CLSK Health Analysis

2.1 Basic Checks

  • CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CLSK has more shares outstanding
  • Compared to 5 years ago, CLSK has more shares outstanding
  • The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.14, we must say that CLSK is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.14, CLSK perfoms like the industry average, outperforming 42.91% of the companies in the same industry.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that CLSK has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.29, CLSK is doing worse than 78.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC10.5%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 10.54 indicates that CLSK has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 10.54, CLSK belongs to the best of the industry, outperforming 94.18% of the companies in the same industry.
  • A Quick Ratio of 10.54 indicates that CLSK has no problem at all paying its short term obligations.
  • CLSK has a better Quick ratio (10.54) than 94.18% of its industry peers.
Industry RankSector Rank
Current Ratio 10.54
Quick Ratio 10.54
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CLSK Growth Analysis

3.1 Past

  • The earnings per share for CLSK have decreased strongly by -237.18% in the last year.
  • The Revenue has grown by 67.96% in the past year. This is a very strong growth!
  • Measured over the past years, CLSK shows a very strong growth in Revenue. The Revenue has been growing by 138.17% on average per year.
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%

3.2 Future

  • CLSK is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -59.52% yearly.
  • CLSK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.97% yearly.
EPS Next Y-212.49%
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%
EPS Next 5YN/A
Revenue Next Year-8.23%
Revenue Next 2Y4.89%
Revenue Next 3Y21.97%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLSK Valuation Analysis

4.1 Price/Earnings Ratio

  • CLSK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 101.60, CLSK can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CLSK.
  • CLSK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.68.
Industry RankSector Rank
PE N/A
Fwd PE 101.6
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLSK is valued cheaper than 85.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.28
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • CLSK's earnings are expected to decrease with -59.52% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLSK Dividend Analysis

5.1 Amount

  • CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLSK Fundamentals: All Metrics, Ratios and Statistics

CLEANSPARK INC

NASDAQ:CLSK (4/10/2026, 3:19:05 PM)

9.975

-0.22 (-2.21%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners82.87%
Inst Owner Change0%
Ins Owners1.84%
Ins Owner Change3.86%
Market Cap2.55B
Revenue(TTM)785.19M
Net Income(TTM)-267.04M
Analysts83
Price Target20.2 (102.51%)
Short Float %34.41%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP-4.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-290.57%
Min EPS beat(2)-478.1%
Max EPS beat(2)-103.04%
EPS beat(4)1
Avg EPS beat(4)-203.45%
Min EPS beat(4)-478.1%
Max EPS beat(4)171.26%
EPS beat(8)3
Avg EPS beat(8)6.91%
EPS beat(12)6
Avg EPS beat(12)-7.59%
EPS beat(16)7
Avg EPS beat(16)-28.99%
Revenue beat(2)0
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-8.67%
Max Revenue beat(2)-7.15%
Revenue beat(4)1
Avg Revenue beat(4)-5.68%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)0.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.55%
Revenue beat(12)4
Avg Revenue beat(12)-2.03%
Revenue beat(16)5
Avg Revenue beat(16)-3.78%
PT rev (1m)0%
PT rev (3m)-19%
EPS NQ rev (1m)-12.83%
EPS NQ rev (3m)-1195.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-1339.76%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-25.92%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-19.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 101.6
P/S 3.25
P/FCF N/A
P/OCF N/A
P/B 1.85
P/tB 2.05
EV/EBITDA 10.28
EPS(TTM)-1.07
EYN/A
EPS(NY)0.1
Fwd EY0.98%
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-1.97
OCFYN/A
SpS3.07
BVpS5.4
TBVpS4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.08%
FCFM N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 8.05
Cap/Depr 38.96%
Cap/Sales 19.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.54
Quick Ratio 10.54
Altman-Z 1.14
F-Score2
WACC10.5%
ROIC/WACCN/A
Cap/Depr(3y)67.81%
Cap/Depr(5y)346.78%
Cap/Sales(3y)33.73%
Cap/Sales(5y)94.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-212.49%
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%
Revenue Next Year-8.23%
Revenue Next 2Y4.89%
Revenue Next 3Y21.97%
Revenue Next 5YN/A
EBIT growth 1Y-167.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-74.4%
EBIT Next 3Y-29.99%
EBIT Next 5YN/A
FCF growth 1Y-306.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-565.42%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLSK.


What is the valuation status of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a valuation rating of 1 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.


How profitable is CLEANSPARK INC (CLSK) stock?

CLEANSPARK INC (CLSK) has a profitability rating of 1 / 10.


What is the financial health of CLEANSPARK INC (CLSK) stock?

The financial health rating of CLEANSPARK INC (CLSK) is 3 / 10.